Al Paruas is categorized under Automated Blood and Body Fluid Analyzers, Except Lab in North Miami Beach, FL and active since 1999.
Al Paruas was established in 1999, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Automated Blood and Body Fluid Analyzers, Except Lab business, which does work in the B2B market, and is classified as a Automated Blood and Body Fluid Analyzers, Except Lab, under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Al Paruas at the company’s single location by writing to 645 Golden Beach Drive, North Miami Beach, Florida FL 33160 or by phoning (305) 932-7989. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Al Paruas |
Contact Person: | Al Paruas |
Address: | 645 Golden Beach Drive, North Miami Beach, Florida 33160 |
Phone Number: | (305) 932-7989 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 1999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Automated Blood and Body Fluid Analyzers, Except Lab |
SIC Code: | 3845 |
NAICS Code: | 334510 |
Share This Business: |
Al Paruas was started in 1999 to provide professional Automated Blood and Body Fluid Analyzers, Except Lab under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Al Paruas for inquiries that concern Al Paruas by calling the company number (305) 932-7989, as your correspondence is most welcome. Additionally, the physical location of the single location of Al Paruas can be found at the coordinates 25.973367,-80.120285 as well as the street address 645 Golden Beach Drive in North Miami Beach, Florida 33160.
For its online presence, you may visit Al Paruas’s website at and engage with its social media outlets through on Twitter and on Facebook.